Eppendorf
Eppendorf AG, a leading name in the life sciences industry, is headquartered in Hamburg, Germany (DE). Founded in 1945, the company has established itself as a pioneer in laboratory equipment and consumables, serving researchers and scientists across the globe. Eppendorf's core business areas include liquid handling, sample handling, and cell culture, with innovative products such as pipettes, centrifuges, and bioreactors that are renowned for their precision and reliability. With a strong presence in Europe, North America, and Asia, Eppendorf has achieved significant milestones, including numerous awards for product excellence and sustainability initiatives. The company is committed to advancing scientific research, making it a trusted partner in laboratories worldwide. Eppendorf's dedication to quality and innovation solidifies its position as a market leader in the life sciences sector.
DitchCarbon Score
How does Eppendorf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eppendorf's score of 23 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eppendorf's reported carbon emissions
In 2022, Eppendorf SE reported total carbon emissions of approximately 700,900 kg CO2e for Scope 1, 1,805,000 kg CO2e for Scope 2 (market-based), and a significant 246,561,000 kg CO2e for Scope 3 emissions, primarily from the use of sold products. The combined total for Scope 1 and 2 emissions was about 8,814,000 kg CO2e. This reflects a slight decrease from 2021, where Scope 1 emissions were 7,193,000 kg CO2e, Scope 2 emissions (market-based) were 2,023,000 kg CO2e, and Scope 3 emissions from the use of sold products were 232,434,000 kg CO2e. Eppendorf has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in sustainability initiatives within the pharmaceuticals, biotechnology, and life sciences sector, and has not yet committed to a net-zero target. Their emissions data is independently reported and not cascaded from a parent company, ensuring transparency in their climate commitments. Overall, Eppendorf's emissions profile highlights the significant impact of Scope 3 emissions, particularly from the use of sold products, indicating a need for focused strategies to address these areas in their sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,644,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,202,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 81,784,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eppendorf is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
